GALAPAGOS N.V. | 90.2800 / +2.78% |
Date/Time | 01/25 / 09:04 |
Chg. / Chg.(%) | 2.4400 / +2.78% |
Bid | 90.7800 / 200 |
Ask | 91.6800 / 200 |
Open | 90.2800 |
Previous Close | 87.8400 |
High | 90.2800 |
Low | 90.2800 |
Volume [EUR] | 0.0000 |
Volume [Units] | 0 |
Price fixings | 1 |
ISIN | BE0003818359 |
Security | GXE |
Exchange | Frankfurt |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Euronext - A.. | 91.08 | ![]() |
120,689 |
Turquoise | 91.08 | ![]() |
8,856 |
Cboe Europe .. | 91.12 | ![]() |
7,940 |
London Inter.. | 91.20 | ![]() |
6,333 |
TradeGate | 90.84 | ![]() |
339 |
Cboe Europe .. | 91.01 | ![]() |
315 |
Cboe Europe .. | 91.18 | ![]() |
101 |
gettex | 91.120 | ![]() |
24 |
Stuttgart | 90.900 | ![]() |
2 |
Düsseldorf | 90.78 | ![]() |
0 |
München | 91.48 | ![]() |
0 |
Berlin | 91.08 | ![]() |
0 |
Frankfurt | 90.2800 | ![]() |
0 |
Vienna Globa.. | 90.84 | ![]() |
0 |
Lang & Schwa.. | 91.08 | ![]() |
|
Xetra | 89.54 | 80 | |
Nasdaq Other.. | 108.0200 | 100,069 |
News
- NICE recommends Jyseleca® ▼(filgotinib) on NHS in landmark decision for rheumatoid arthritis
01/21/2021 / 08:08 - GlobeNewswire - Oxurion NV appoints Prof Alan Stitt as Chief Scientific Officer
01/20/2021 / 08:00 - GlobeNewswire - Gilead holds 25.54% of Galapagos shares
01/11/2021 / 22:01 - GlobeNewswire - OXURION to Participate in Upcoming Investor Meetings
01/07/2021 / 08:00 - GlobeNewswire - Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
01/06/2021 / 15:30 - GlobeNewswire